about
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsLate erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsEarly versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsLate erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsEarly erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsFolic acid supplementation for the prevention of anaemia in preterm neonatesLate erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsEarly erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsThe effects of umbilical cord milking in extremely preterm infants: a randomized controlled trial.Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis.Does erythropoietin protect the preterm brain?Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants.Comparison of oral recombinant erythropoietin and subcutaneous recombinant erythropoietin in prevention of anemia of prematurity.Recent advances in neonatal pharmacotherapy.Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats.Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple.Erythropoietin in anemia of prematurity.Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity.Early erythropoiesis-stimulating agents in preterm or low birth weight infants.Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.Erythropoietin may attenuate lung inflammation in a rat model of meconium aspiration syndrome.Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study.
P2860
Q24195000-8E67BDB6-97BB-4403-9B25-F1BFD4B17153Q24195008-01179F15-33E4-4C9D-9E07-C495949F27EAQ24197981-E18361AC-AFBE-4FDF-AB36-44AF1DF1EA68Q24200513-7BBA3F9A-7191-49F6-9B41-0B57B4A88E85Q24200642-F63C93DA-E467-4204-A959-F4B29BC6A609Q24236328-F51B0520-19ED-4E14-A121-17FD39A98170Q24245263-621C39EA-BBCA-43E9-9E79-4206D99CE5DCQ24245418-E19183EB-24AB-41D0-9777-E7524DA30DCCQ30571202-A57A0EE2-AD51-463A-83DC-37409F7F667AQ34565026-AC7A49E3-408E-437E-9888-8A8C4332C2ECQ35813472-EBD4A2C7-9D2C-4869-8C5D-8E483F5D1DC1Q35924381-D5ECCC00-EA47-48B4-96B9-EF81775C16EFQ36022650-5D52E37D-9625-496C-B6E0-5E12509AAE11Q36434300-93B4927A-7F40-4CCF-98B1-A21BA879F424Q37223145-C5CA987C-D910-4C02-ADC3-10CAD6A1F14BQ37375095-F056AB3D-3D56-4294-AFEF-1724C02773C9Q38048378-0B556A31-EF75-44FD-94C9-E9B293D8BEDCQ41886821-DC65C021-1716-4B97-9436-3001E3056BD1Q47176323-6FD136BE-E1AA-44F9-B77C-07AC1CDC9A1BQ47262085-49C8DF74-8F9C-4AFE-A532-A80349ACE3EAQ51512251-489C6126-D717-4B2E-B964-EF97BDCD379CQ52643860-10E46EB7-5A95-4FB5-BDD8-B9F17C2726B2
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The use of erythropoietin in neonates.
@ast
The use of erythropoietin in neonates.
@en
The use of erythropoietin in neonates.
@nl
type
label
The use of erythropoietin in neonates.
@ast
The use of erythropoietin in neonates.
@en
The use of erythropoietin in neonates.
@nl
prefLabel
The use of erythropoietin in neonates.
@ast
The use of erythropoietin in neonates.
@en
The use of erythropoietin in neonates.
@nl
P1476
The use of erythropoietin in neonates.
@en
P2093
P304
P356
10.1016/S0095-5108(05)70045-2
P577
2000-09-01T00:00:00Z